Clinical trials

5

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

DECIDE Just Culture: Conceptualization of Clinical Error

The main objective of this project is to extend the principles of Just Culture in primary care, hospitals and social-health centers, providing new information on key elements in the social and professional conceptualization of the human factor (fallibility) in safety incidents. A mixed design combining cross-sectional observational studies based on qualitative (focus groups and consensus conference) and quantitative (survey) methodology with an experimental study or randomized clinical trial with three arms will be used. The methodology is deployed in four stages or phases of the study: 1. Focus Group technique (qualitative research) with 70 primary care health professionals, 80 hospital health professionals, 70 health professionals from socio-health centers, 72 health managers and 80 social leaders to identify key elements of the subjective norms and social influence processes that define the conceptualization of a clinical error, including impact of gender bias and other stereotypes in relation to blame. 2. Online survey of a stratified random sample of 1,255 managers, middle managers and professionals from primary care, hospitals and social-health centers to analyze the barriers and facilitating factors for the implementation of Just Culture. 3. Randomized experimental study with three arms (84 subjects in each) and control group to determine the effectiveness of two interventions aimed at modifying attitudes, beliefs and behaviors in relation to honest mistakes, based on the Theory of Dissonance and Reasoned Action, both in social leaders and professionals. 4. Application of AGREE II and Consensus Conference technique (33 experts) to elaborate a guide of recommendations in order to implement Just Culture in primary care, with the involvement of all actors (social and professional level) that will be transferred to practice.

Participants needed: 1,255
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat ValencianaUpdated: Apr 29, 2026Locations: 1
Eligibility criteria

Over 18 years of age, health professionals in primary care, hospitals or social-...

Inclusion criteria: Managers of health centers, hospitals or socio-health center... [+3]

Status: Not yet recruiting

Efficacy of a Polyhexanide Biguanide-Based Gel in the Prevention of Biofilm Formation in Pressure Ulcers

INTRODUCTION: Pressure ulcers (PU) are one of the main challenges for nursing in our country. Wound bed preparation and the TIME algorithm provide essential tools for adequately treating these lesions. However, these wounds tend to become chronic due to the bacterial load in their bed. It is now known that bacteria can form complex and diverse structures, named as biofilm, which are difficult to diagnose and much more resistant to antimicrobial action. Controlling these biofilms is crucial to create the optimal conditions for wound healing. Currently, it is believed that biofilms are present in 60-100% of chronic wounds. Therefore, more studies are needed to evaluate the efficacy of different antimicrobial agents on these structures. OBJECTIVE: To determine the efficacy of a gel containing polyhexanide and biguanide, alone or in combination with alginate with or without silver, in preventing biofilm in PU, in terms of healing at 4 weeks. METHODOLOGY: Multicenter clinical trial with a 2x2 factorial design, conducted with patients from Alcoy with category II and III PUs that meet the inclusion and exclusion criteria. A sample of 140 participants is estimated, distributed into four groups of 35 patients. The interventions that will be carried out will be: application of Prontosan gel® and Aquacel Ag+®; Aquacel Ag+®; control group; Prontosan gel®. Data on wound evolution will be collected using RESVECH 2.0. Descriptive statistical analysis and hypothesis testing will be performed.

Participants needed: 140
Trial details
Phase: Early Phase 1Age: 65+Biological sex: AllType: InterventionalSponsor: Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat ValencianaUpdated: Feb 10, 2026
Eligibility criteria

Bedridden patients, patients with bed-to-chair mobility, or those in a wheelchai... [+5]

Patients who, despite the above, present a deteriorated health status that could... [+2]

Status: Recruiting

Colorectal Surgery, a New Robotic Platform (Hugo Ras)

A novel robotic platform -Hugo Robotic Assisted Surgery (RAS)- has been introduced with several innovations that may prove advantageous for surgeons such as an open console and four interchangeable modular arms. Our study aims to evaluate the safety, efficacy and potential impact of this platform in the surgical treatment of colorectal pathology.

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat ValencianaUpdated: Jul 23, 2024Locations: 1Duration: 1 Year
Eligibility criteria

Pacientes intervenidos de forma programada de procedimientos en cirugía colorrec... [+1]

Pacientes intervenidos mediante abordaje inicial laparoscópico o abierto. [+6]

Status: Not yet recruiting

Technologies to Improve QoL of Prostate Cancer

The M.I.O Project, which stands for Comprehensive Oncological Medicine, aims to comprehensively and multidisciplinary address the effects of prostate cancer, specifically in patients with hormone-sensitive metastatic prostate cancer (HSMPC), an advanced stage of the disease that still offers prolonged survival due to new medications. The proposal seeks to develop a healthcare approach that promotes self-care and improves the physical and mental health of patients. Despite growing scientific evidence supporting an integrative approach in oncological care, the provision of personalized options for exercise, nutrition, and psychological therapy before, during, and after diagnosis remains limited. The project proposes to develop tools such as a dedicated mobile application that provides HSMPC patients access to various resources and therapies to improve their health, focusing on nutrition, exercise, and emotional well-being. M.I.O represents an innovative and holistic approach to addressing these patients' needs and improving their overall well-being. The main goal is to measure the quality of life of the application users through validated questionnaires in a randomized health education study to assess if there is a substantial improvement in their well-being.

Participants needed: 98
Trial details
Biological sex: MaleType: InterventionalSponsor: Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat ValencianaUpdated: Jul 23, 2024
Eligibility criteria

Patients histologically diagnosed with prostate cancer [+2]

Do not have a smartphone device [+2]

Status: Recruiting

Organ Preservation in Locally Advanced Rectal Cancer

PRONAR trial aims to assess if treatment with organ preservation in stage II and III rectal cancer after a complete or almost complete response to neoadjuvant treatment is feasible and safe in our environment. The main objective of this project is to implement the organ preservation strategy in the treatment of rectal cancer in our environment within a clinical study that allows the analysis of its results in terms of survival. The secondary objective is to assess local relapse, distant relapse and quality of life.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat ValencianaUpdated: Sep 27, 2018Locations: 1
Eligibility criteria

Patients with confirmed histopathological diagnosis of rectal adenocarcinoma. [+2]

Evidence of distant metastases.